Radioimmunoconjugate
Showing 1 - 8 of 8
Advanced Solid Tumours, Actinium-225, Antineoplastic Agents Trial in Australia, Canada, United States ([111In]-FPI-1547
Recruiting
- Advanced Solid Tumours
- +4 more
- [111In]-FPI-1547 Injection
- +3 more
-
Duarte, California
- +12 more
Mar 2, 2022
Non-Hodgkin Lymphoma, Follicular Lymphoma Trial in Worldwide (Betalutin)
Active, not recruiting
- Non-Hodgkin Lymphoma
- Follicular Lymphoma
-
Little Rock, Arkansas
- +95 more
Sep 9, 2022
Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma, Bladder Carcinoma Trial in Duarte, Iowa City, New York
Recruiting
- Advanced Solid Tumor
- +13 more
- [225Ac]-FPI-1966
- +2 more
-
Duarte, California
- +3 more
Oct 25, 2022
Lymphoma, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Non-Hodgkin Trial in United States (Autologous transplantation
Completed
- Lymphoma, B-Cell
- +2 more
- Autologous transplantation using rituxan/BEAM
- Autologous transplantation using Bexxar/BEAM
-
New Haven, Connecticut
- +35 more
Oct 21, 2021
Non-Hodgkin Lymphoma Trial in Würzburg (Betalutin with lilotomab dose 1, Betalutin with lilotomab dose 2)
Withdrawn
- Non-Hodgkin Lymphoma
- Betalutin with lilotomab dose 1
- Betalutin with lilotomab dose 2
-
Würzburg, GermanyUniversitätsklinikum Würzburg
Jan 8, 2019
MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in Rochester (rituximab, yttrium Y 90
Terminated
- Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
- +8 more
- rituximab
- +4 more
-
Rochester, MinnesotaMayo Clinic
Jul 9, 2018
Follicular Lymphoma Trial in Toronto (Y90 Ibritumomab Tiuxetan RIT)
Completed
- Follicular Lymphoma
- Y90 Ibritumomab Tiuxetan RIT
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre, Odette Cancer Centre
Jun 15, 2016